RAC1 and pancreatic neoplasm: Results in Figs. 1–6 showed that the IR-induced G2/M checkpoint activation in human pancreatic cancer cells was abrogated by the Rac1 specific inhibitor NSC23766 and by expression of the N17Rac1 mutant.